Sugary drinks and increased colon cancer risk linked in study involving nurses Young adults who drink sugary beverages may be at an increased risk of developing colon cancer, researchers claim.
How to treat a sunburn: Signs to watch for this summer Millions of Americans are headed to the beach or an outdoor BBQ with friends and family to celebrate the Fourth of July this weekend, meaning hours of potential sun exposure which could lead to sunburn.
Kathy Giusti: Warp Speed to cancer cures – COVID vaccine should be our model to save more lives If the speed of COVID-19 vaccine development and distribution has taught us anything, it’s that when government funds not just the discovery, but application and commercialization of life-saving medical treatment, it can de-risk the private sector in ways that will drive quick action.
Early pandemic spurred ‘sharp declines’ in breast and cervical cancer screenings: CDC Screenings for breast and cervical cancer among low income women plummeted early in the pandemic, with test volume picking up into the summer, according to a study linking the declines to pandemic-related closures and patients' fear of COVID-19 infection.
Blink 182's Mark Hoppus gives fans an update on his cancer treatment Mark Hoppus shared with fans that he was feeling 'much better' amid cancer treatment while speaking with fans on Twitch.
Drinking coffee may reduce risk of getting liver cancer A new study brews up some good news for avid coffee drinkers.
'Friends' star James Michael Tyler details prostate cancer battle The actor, who played Gunther in the series, was diagnosed in 2018 and is now battling stage 4 cancer.
Novartis experimental prostate cancer drug gets FDA breakthrough designation Novartis announced on Wednesday that the FDA granted Breakthrough Therapy designation to an experimental therapy that targets advanced castration-resistant prostate cancer.
Breast cancer pill shows benefit in certain hard-to-treat cases A pill has been shown to help keep certain early-stage, hard-to-treat breast cancers at bay after initial treatment in findings being reported early because they are so promising.
FDA greenlights targeted therapy for lung cancer mutation The Food and Drug Administration has approved the first drug for a specific mutation causing lung cancer in adult patients who have undergone at least one systemic treatment, such as chemotherapy.
